Q32 Bio (QTTB) Return on Sales (2018 - 2024)

Q32 Bio's Return on Sales history runs 7 years deep, the most recent figure standing at 0.43% for Q3 2024.

• On a quarterly basis, Return on Sales rose 51.0% year-over-year to 0.43% in Q3 2024; TTM through Sep 2024 was 0.43%, a 50.0% increase from a year earlier, with the FY2025 full-year figure at 0.01%, changed N/A from the prior year.
• Return on Sales advanced to 0.43% in Q3 2024 per QTTB's latest filing, from 1.11% in the prior quarter.
• Across five years, Return on Sales topped out at 1.16% in Q1 2022 and bottomed at 1.58% in Q4 2020.
• The 5-year median for Return on Sales is 0.17% (2021), against an average of 0.3%.
• Across the five-year window, Return on Sales soared 201 bps in 2020 and slumped 118 bps in 2023, its largest moves.
• Year by year, Return on Sales stood at 1.58% in 2020, then surged by 89 bps to 0.17% in 2021, then slumped by 156 bps to 0.43% in 2022, then soared by 146 bps to 0.2% in 2023, then soared by 118 bps to 0.43% in 2024.
• Per Business Quant, the three latest QTTB Return on Sales figures stand at 0.43% (Q3 2024), 1.11% (Q2 2024), and 0.12% (Q1 2024).